✦ LIBER ✦

765 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER

✍ Scribed by B.W.G. Van Rhijn; P.J. Bostrom; S.F. Shariat; A. Finelli; A.I. Sagalowsky; N.E. Fleshner; B. Bapat; H. Kortekangas; R. Ashfaq; T. Mirtti; M.A.S. Jewett; Y. Lotan; Th.H. Van Der Kwast; A.R. Zlotta

Book ID: 119623104
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 176 KB
Volume: 10
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(11)60753-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1401 THE FGFR3 MUTATION IDENTIFIES PATIE

1401 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER

✍ van Rhijn, Bas W.; Bostrom, Peter J.; Shariat, Shahrokh F.; Finelli, Antonio; Sa 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 95 KB

603 FGFR3 PROTEIN OVER-EXPRESSION IN THE

603 FGFR3 PROTEIN OVER-EXPRESSION IN THE ABSENCE OF A FGFR3 MUTATION IS NOT ASSOCIATED WITH FAVORABLE DISEASE CHARACTERISTICS IN BLADDER CANCER

✍ Rhijn B.W.G. Van; B. Bapat; L. Liyang; P.J. Bostrom; N.E. Fleshner; M.A.S. Jewet 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Disease-Free Survival at 2 or 3 Years Co

Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer

✍ Sonpavde, Guru; Khan, Myrna M.; Lerner, Seth P.; Svatek, Robert S.; Novara, Giac 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 260 KB

530 EXTERNAL VALIDATION OF DISEASE-FREE

530 EXTERNAL VALIDATION OF DISEASE-FREE SURVIVAL AT 2 OR 3 YEARS AS A SURROGATE AND NEW PRIMARY ENDPOINT FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER OF THE BLADDER

✍ Bastian, Patrick J.; May, Matthias; Fritsche, Hans-Martin; Buchner, Alexander; B 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 179 KB

External validation of disease-free surv

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

✍ P. Nuhn; M. May; H.-M. Fritsche; A. Buchner; S. Brookman-May; C. Bolenz; R. Mori 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 336 KB

177 THE PROGNOSTIC VALUE OF FGFR3 MUTATI

177 THE PROGNOSTIC VALUE OF FGFR3 MUTATIONAL STATUS FOR DISEASE RECURRENCE AND PROGRESSION DEPENDS ON ALLELIC LOSSES AT 9P22: A PROSPECTIVE AND PRELIMINARY STUDY IN 58 NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS

✍ G. Ploussard; H. Soliman; F. Dubosq; J. Vérine; F. Desgrandchamps; Thé H. De; P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 176 KB